T. Rowe Price Associates’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$103K Buy
2025
Q2
$100K Buy
2025
Q1
$50K Buy
2024
Q4
$63K Buy
2024
Q3
$240K Buy
2024
Q2
$0 Buy
2022
Q1
Sell
2021
Q4
$24K Hold
2021
Q3
$39K Hold
2021
Q2
$49K Hold
2021
Q1
$67K Buy